Follow

Submissions from 2023

Link

Tapinarof Validates the Aryl Hydrocarbon Receptor as a Therapeutic Target: A Clinical Review, Jonathan I. Silverberg, Mark Boguniewicz, Francisco J. Quintana, Rachael A. Clark, Lara Gross, Ikuo Hirano, Anna M. Tallman, Philip M. Brown, Doral Fredericks, David S. Rubenstein, and Kimberly A. McHale

Link

Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis, Jonathan I. Silverberg, Marjolein de Bruin-Weller, Brian M. Calimlim, Xiaofei Hu, Sarah A. Ofori, Andrew M. Platt, Henrique D. Teixeira, Kilian Eyerich, and Jacob P. Thyssen

Link

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis, Jonathan I. Silverberg, Emma Guttman-Yassky, Diamant Thaçi, Alan D. Irvine, Linda Stein Gold, Andrew Blauvelt, Eric L. Simpson, Chia-Yu Chu, Zhuqing Liu, Renata Gontijo Lima, Sreekumar G. Pillai, and Julien Seneschal

Link

Development of an Eczema Area and Severity Index Atlas for Diverse Skin Types, Jonathan I. Silverberg, Joshua Horeczko, and Andrew Alexis

Link

A Mini Review of the Impact of Baseline Disease Severity on Clinical Outcomes: Should We Compare Atopic Dermatitis Clinical Trials?, Jonathan I. Silverberg, Selwyn Ho, and Raúl Collazo

Link

Psychometric evaluation of the Worst Pruritus Numerical Rating Scale (NRS), Atopic Dermatitis Symptom Scale (ADerm-SS), and Atopic Dermatitis Impact Scale (ADerm-IS), Jonathan I. Silverberg, Yael A. Leshem, Brian M. Calimlim, Jeffrey McDonald, and Leighann Litcher-Kelly

Link

Psychometric evaluation of the Worst Pruritus Numerical Rating Scale (NRS), Atopic Dermatitis Symptom Scale (ADerm-SS), and Atopic Dermatitis Impact Scale (ADerm-IS), Jonathan I. Silverberg, Yael A. Leshem, Brian M. Calimlim, Jeffrey McDonald, and Leighann Litcher-Kelly

Link

Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trial, Jonathan I. Silverberg, Peter A. Lio, Eric L. Simpson, Connie Li, Daniel R. Brownell, Ioannis Gryllos, Judith Ng-Cashin, Todd Krueger, Victoria R. Swaidan, Robin L. Bliss, and Hyun D. Kim

Link

Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials, Jonathan I. Silverberg, Charles W. Lynde, Katrina Abuabara, Cataldo Patruno, Anna de Benedetto, Haixin Zhang, Ryan B. Thomas, Gaëlle Bégo-Le-Bagousse, Faisal A. Khokhar, Jignesh Vakil, Ainara Rodríguez Marco, and Noah A. Levit

Link

Burden of Disease and Unmet Needs in Atopic Dermatitis: Results From a Patient Survey, Jonathan I. Silverberg, Jennifer A. Mohawk, Joshua Cirulli, Kristine Nograles, Joseph C. Punzalan, Kevin M. Kelly, Brian S. Kim, Emma Guttman-Yassky, and Mark Lebwohl

Link

Patch Testing With Nickel, Cobalt, and Chromium in Patients With Suspected Allergic Contact Dermatitis, Jonathan I. Silverberg, Nisha Patel, Erin M. Warshaw, Joel G. DeKoven, Donald V. Belsito, Amber R. Atwater, James S. Taylor, Denis Sasseville, Margo J. Reeder, Marie-Claude Houle, Vincent A. DeLeo, Howard I. Maibach, Joseph F. Fowler, Kathryn A. Zug, Melanie D. Pratt, JiaDe Yu, Christen M. Mowad, Nina C. Botto, and Brandon L. Adler

Link

Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry, Jonathan I. Silverberg, Evangeline Pierce, Meghan Feely, Amber Reck Atwater, Amy Schrader, Eric A. Jones, Swapna S. Dave, and Eric L. Simpson

Link

Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry, Jonathan I. Silverberg, Vivian Y. Shi, Andrew Alexis, Evangeline Pierce, Angel Cronin, Robert R. McLean, Carla Roberts-Toler, Maria J. Rueda, Amber R. Atwater, and Eric Simpson

Link

Prevalence and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: A Cross Sectional Study from the TARGET-DERM AD Cohort, Jonathan I. Silverberg, Brenda Simpson, Katrina Abuabara, Emma Guttman-Yassky, Brian Calimlim, Colleen Wegzyn, Whitney Krueger, Amy Gamelli, Breda Munoz, Rachel W. Faller, Julie M. Crawford, Ayman Grada, and Lawrence F. Eichenfield

Link

Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension, Jonathan Silverberg, J Mark Jackson, Robert S. Kirsner, Roni Adiri, Gary Friedman, Xing-Hua Gao, Steven D. Billings, and Urs Kerkmann

Link

Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibition, Eric L. Simpson, Emma Guttman-Yassky, Lawrence F. Eichenfield, Mark Boguniewicz, Thomas Bieber, Shannon Schneider, Adriana Guana, and Jonathan I. Silverberg

Link

Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial, Eric L. Simpson, Jonathan I. Silverberg, Jacob P. Thyssen, Manuelle Viguier, Diamant Thaçi, Marjolein de Bruin-Weller, Stephan Weidinger, Gary Chan, Marco DiBonaventura, Pinaki Biswas, Claire Feeney, Christopher Koulias, and Michael J. Cork

Link

Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial, Eric L. Simpson, Jonathan I. Silverberg, Jacob P. Thyssen, Manuelle Viguier, Diamant Thaçi, Marjolein de Bruin-Weller, Stephan Weidinger, Gary Chan, Marco DiBonaventura, Pinaki Biswas, Claire Feeney, Christopher Koulias, and Michael J. Cork

Link

Outpatient utilization patterns for atopic dermatitis in the United States, Partik Singh and Jonathan I. Silverberg

Link

Correlation of clinician-reported outcomes with patient-reported outcomes by race and ethnicity in patients with atopic dermatitis, Jourdan Hydol Smith and Jonathan I. Silverberg

Link

Largest comparative analysis: Novel large spot size 595 nm, high-energy, pulsed dye laser reduces number of treatments for improvement of adult and pediatric port wine birthmarks, Pooja Sodha, Jordan V. Wang, Nader Aboul-Fettouh, Katherine Martin, Roy G. Geronemus, and Paul M. Friedman

Link

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study, Howard Sofen, Robert Bissonnette, Gil Yosipovitch, Jonathan I. Silverberg, Stephen Tyring, Wei Jing Loo, Matthew Zook, Mark Lee, Liangxing Zou, Guang-Liang Jiang, and John F. Paolini

Link

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study, Howard Sofen, Robert Bissonnette, Gil Yosipovitch, Jonathan I. Silverberg, Stephen Tyring, Wei Jing Loo, Matthew Zook, Mark Lee, Liangxing Zou, Guang-Liang Jiang, and John F. Paolini

Link

Berdazimer gel for molluscum contagiosum: An integrated analysis of 3 randomized controlled trials, Jeffrey L. Sugarman, Adelaide Hebert, John C. Browning, Amy S. Paller, Stephen Stripling, Lawrence J. Green, Martina Cartwright, Carolyn Enloe, Nick Wells, and Tomoko Maeda-Chubachi

Link

Comorbidities of atopic dermatitis-what does the evidence say?, Jacob P. Thyssen, Anne-Sofie Halling, Peter Schmid-Grendelmeier, Emma Guttman-Yassky, and Jonathan I. Silverberg

Link

Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose study, Karen A. Veverka, Steven T. Thng, Jonathan I. Silverberg, April W. Armstrong, Josemund Menezes, Alexandre Kaoukhov, and Andrew Blauvelt

Link

Patch Testing to Chlorhexidine Digluconate, 1% Aqueous: North American Contact Dermatitis Group Experience, 2015-2020, Erin M. Warshaw, Joohee Han, Sara A. Kullberg, Joel G. DeKoven, Brandon L. Adler, Jonathan I. Silverberg, Marie-Claude Houle, Melanie D. Pratt, Donald V. Belsito, Jiade Yu, Nina C. Botto, Margo J. Reeder, James S. Taylor, Amber R. Atwater, Cory A. Dunnick, Vincent A. DeLeo, and Chris M. Mowad

Link

Patch Testing to Paraphenylenediamine: The North American Contact Dermatitis Group Experience (1994-2018), Erin M. Warshaw, Malina Yamashita Peterson, Amber R. Atwater, Joel G. DeKoven, Melanie D. Pratt, James S. Taylor, Donald V. Belsito, Jonathan I. Silverberg, Margo J. Reeder, Vincent A. DeLeo, Marie-Claude Houle, Cory A. Dunnick, Jiade Yu, Brandon Adler, Christen Mowad, and Nina C. Botto

Long-term Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Rosacea: Results From an Extension of Two Phase III, Vehicle-controlled Trials, William P. Werschler, Jeffrey Sugarman, Neal Bhatia, Hilary Baldwin, Lawrence J. Green, Ori Nov, Vered Ram, Ofra Levy-Hacham, and Linda Stein Gold

Link

Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management, Gil Yosipovitch, Susan T. Nedorost, Jonathan I. Silverberg, Adam J. Friedman, Juliana M. Canosa, and Amy Cha

Link

Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management, Gil Yosipovitch, Susan T. Nedorost, Jonathan I. Silverberg, Adam J. Friedman, Juliana M. Canosa, and Amy Cha

Link

Patch Test Results Among Older Adults: A Retrospective Analysis of the North American Contact Dermatitis Group Data (2009-2020), JiaDe Yu, Hadley Johnson, Joel G. DeKoven, Erin M. Warshaw, James S. Taylor, Donald V. Belsito, Brandon L. Adler, Jonathan I. Silverberg, Amber R. Atwater, Margo J. Reeder, Nina Botto, Marie-Claude Houle, Christen M. Mowad, Melanie D. Pratt, and Cory A. Dunnick

Link

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial, Matthew J. Zirwas, Zoe D. Draelos, Janet DuBois, Leon H. Kircik, Angela Y. Moore, Linda Stein Gold, Javier Alonso-Llamazares, Michael Bukhalo, Suzanne Bruce, Kimmie Eads, Lawrence J. Green, Scott T. Guenthner, Laura K. Ferris, Seth B. Forman, Steven E. Kempers, Edward Lain, Charles W. Lynde, David M. Pariser, Darryl P. Toth, Paul S. Yamauchi, Robert C. Higham, David Krupa, Patrick Burnett, and David R. Berk

Link

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial, Matthew J. Zirwas, Zoe D. Draelos, Janet DuBois, Leon H. Kircik, Angela Y. Moore, Linda Stein Gold, Javier Alonso-Llamazares, Michael Bukhalo, Suzanne Bruce, Kimmie Eads, Lawrence J. Green, Scott T. Guenthner, Laura K. Ferris, Seth B. Forman, Steven E. Kempers, Edward Lain, Charles W. Lynde, David M. Pariser, Darryl P. Toth, Paul S. Yamauchi, Robert C. Higham, David Krupa, Patrick Burnett, and David R. Berk

Submissions from 2022

Link

Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort, Katrina Abuabara, Lawrence F. Eichenfield, Robert Bissonnette, Jonathan I. Silverberg, Jerry Bagel, Emma Guttman-Yassky, Diamant Thaci, Eric L. Simpson, John E. Harris, James Krueger, Daniela E. Myers, Amy Gamelli, Marina Milutinovic, Anne Parneix, Julie M. Crawford, Breda Munoz, and Amy S. Paller

Link

Benign Familial Pemphigus, Nagasai C. Adusumilli and Adam J. Friedman

Link

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region, Milan J. Anadkat, Mario Lacouture, Adam Friedman, Zachary D. Horne, Jae Jung, Benjamin Kaffenberger, Sujith Kalmadi, Liza Ovington, Rupesh Kotecha, Huda Ismail Abdullah, and Federica Grosso

Link

Shoe Allergens: A Retrospective Analysis of Cross-sectional Data From the North American Contact Dermatitis Group, 2005-2018, Amber Reck Atwater, Raina Bembry, Cynthia L. Green, Joel G. DeKoven, Erin M. Warshaw, Donald V. Belsito, Howard I. Maibach, Jonathan I. Silverberg, James S. Taylor, Margo J. Reeder, Kathryn A. Zug, Joseph F. Fowler, Melanie D. Pratt, Denis Sasseville, and Vincent A. DeLeo

Link

Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE, Layla Bakaa, Jeffrey M. Pernica, Rachel J. Couban, Kelly Jo Tackett, Craig N. Burkhart, Liz Leins, Joanne Smart, Maria Teresa Garcia-Romero, Itzel Guadalupe Elizalde-Jiménez, Michael Herd, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Lina Chen, Kathy Ellison, Winfred Frazier, Matthew Greenhawt, Joey Huynh, Jennifer LeBovidge, Mary Laura Lind, Peter Lio, Monica O'Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Julie Wang, Wendy Smith Begolka, Lynda Schneider, and Derek K. Chu

Link

The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study, Sebastien Barbarot, Jonathan I. Silverberg, Abhijit Gadkari, Eric L. Simpson, Stephan Weidinger, Paola Mina-Osorio, Ana B. Rossi, Lysel Brignoli, Tarek Mnif, Isabelle Guillemin, Miriam C. Fenton, Marine Pellan, Puneet Mahajan, Dimittri Delevry, Ashish Bansal, and Laurent Eckert

Link

Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summary, Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Diamant Thaçi, Carle Paul, Andrew E. Pink, Yoko Kataoka, Chia-Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana Ionita, Rodney Sinclair, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, and Hernan Valdez

Link

Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3, Andrew Blauvelt, Melinda Gooderham, Neal Bhatia, Richard G. Langley, Shannon Schneider, John Zoidis, Azra Kurbasic, April Armstrong, and Jonathan I. Silverberg

Link

Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis, Andrew Blauvelt, Leon Kircik, Kim A. Papp, Eric L. Simpson, Jonathan I. Silverberg, Brian S. Kim, Shawn G. Kwatra, Michael E. Kuligowski, May E. Venturanza, Shaoceng Wei, and Jacek C. Szepietowski

Link

Itch-Free State in Patients With Atopic Dermatitis Treated With Ruxolitinib Cream: Pooled Analysis From Two Randomized Phase 3 Studies, Andrew Blauvelt, Jacek C. Szepietowski, Kim Papp, Eric L. Simpson, Jonathan I. Silverberg, Brian S. Kim, Shawn G. Kwatra, Michael E. Kuligowski, May E. Venturanza, Shaoceng Wei, and Leon Kircik

Link

Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies, Lisa Bloudek, Lawrence F. Eichenfield, Jonathan I. Silverberg, Vijay N. Joish, Jennifer H. Lofland, Kang Sun, Matthias Augustin, Kristen Migliaccio-Walle, and Sean D. Sullivan

Link

Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity, Otavio Cabral-Marques, Gilad Halpert, Lena F. Schimke, Yuri Ostrinski, Aristo Vojdani, Gabriela Crispim Baiocchi, Paula Paccielli Freire, Igor Salerno Filgueiras, Israel Zyskind, Miriam T. Lattin, Florian Tran, Stefan Schreiber, Alexandre H. Marques, Desirée Rodrigues Plaça, Dennyson Leandro Fonseca, Jens Y. Humrich, Antje Müller, Lasse M. Giil, Hanna Graßhoff, Anja Schumann, Alexander Hackel, Juliane Junker, Carlotta Meyer, Hans D. Ochs, Yael Bublil Lavi, Carmen Scheibenbogen, Ralf Dechend, Igor Jurisica, Kai Schulze-Forster, Jonathan I. Silverberg, Howard Amital, and Jason Zimmerman

Link

Longitudinal course and predictors of depressive symptoms in atopic dermatitis, Sheena Chatrath, Donald Lei, Muhammad Yousaf, Rajeev Chavda, Sylvie Gabriel, and Jonathan I. Silverberg

Link

Atopic Dermatitis Is Associated With Lower Patient Satisfaction in US Adults, Brian T. Cheng and Jonathan I. Silverberg

Link

Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States, Raj Chovatiya, Wendy Smith Begolka, Isabelle J. Thibau, and Jonathan I. Silverberg

Link

Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States, Raj Chovatiya, Wendy Smith Begolka, Isabelle J. Thibau, and Jonathan I. Silverberg

Link

DESCRIBE-AD: A novel classification framework for atopic dermatitis, Raj Chovatiya and Jonathan I. Silverberg

Link

Evaluating the longitudinal course of atopic dermatitis: A review of the literature, Raj Chovatiya and Jonathan I. Silverberg

Link

Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice, Raj Chovatiya and Jonathan I. Silverberg

Link

Iatrogenic Burden of Atopic Dermatitis, Raj Chovatiya and Jonathan I. Silverberg

Link

Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries, Joel J. Credle, Jonathan Gunn, Puwanat Sangkhapreecha, Daniel R. Monaco, Xuwen Alice Zheng, Hung-Ji Tsai, Azaan Wilbon, William R. Morgenlander, Andre Rastegar, Yi Dong, Sahana Jayaraman, Lorenzo Tosi, Biju Parekkadan, Alan N. Baer, Mario Roederer, Evan M. Bloch, Aaron A. Tobian, Israel Zyskind, Jonathan I. Silverberg, Avi Z. Rosenberg, Andrea L. Cox, Tom Lloyd, Andrew L. Mammen, and H Benjamin Larman

Link

AAD Guidelines: awareness of comorbidities associated with atopic dermatitis in adults, Dawn M. Davis, Aaron M. Drucker, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Jonathan I. Silverberg, Anne Marie Singh, and Robert Sidbury

Link

Sleep impairment in patients with chronic inflammatory skin diseases: A review of mechanisms and management, Grace Y. Duan and Jonathan I. Silverberg

Link

An intertriginous eruption in an infant, Adaora Ewulu, Michael A. Cardis, and Kaiane A. Habeshian

Link

1,550 nm Erbium-Doped and 1,927 nm Thulium Nonablative Fractional Laser System: Best Practices and Treatment Setting Recommendations, Paul M. Friedman, Jeffrey S. Dover, Anne Chapas, Zakia Rahman, Edward V. Ross, Suzanne L. Kilmer, Wendy E. Roberts, Pooja Sodha, Julie B. Stimmel, Mary Beth Moncrief, and Jill S. Waibel

Link

Clinical features and eosinophilia in pityriasis rubra pilaris: A multicenter cohort, Shilpa Ghatnekar, Nidhi Shah, Michelle S. Min, Daniel R. Mazori, Avery H. LaChance, Ruth Ann Vleugels, and Vinod E. Nambudiri

Link

Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial, Melinda J. Gooderham, Giampiero Girolomoni, Julian O. Moore, Jonathan I. Silverberg, Robert Bissonnette, Seth Forman, Elena Peeva, Pinaki Biswas, Hernan Valdez, and Gary Chan

Link

Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial, Melinda J. Gooderham, Giampiero Girolomoni, Julian O. Moore, Jonathan I. Silverberg, Robert Bissonnette, Seth Forman, Elena Peeva, Pinaki Biswas, Hernan Valdez, and Gary Chan

Enhancing Topical Pharmacotherapy for Acne and Rosacea: Vehicle Choices and Outcomes, Lawrence J. Green, Edward Lain, Thomas Prunty, and Robert Rhoades

Link

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma, Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo B. Su, Paul L. Swiecicki, Jennifer Atlas, Jessica L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett G. Hughes, Dirk Schadendorf, Vishal A. Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Howard L. Kaufman, Frank Seebach, Israel Lowy, Suk-Young Yoo, Melissa Mathias, Keilah Fenech, Hyunsil Han, Matthew G. Fury, and Danny Rischin

Link

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma, Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo B. Su, Paul L. Swiecicki, Jennifer Atlas, Jessica L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett G. Hughes, Dirk Schadendorf, Vishal A. Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Howard L. Kaufman, Frank Seebach, Israel Lowy, Suk-Young Yoo, Melissa Mathias, Keilah Fenech, Hyunsil Han, Matthew G. Fury, and Danny Rischin

Link

Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study, Sigrídur Lára Gudmundsdóttir, Tommaso Ballarini, María L. Ámundadóttir, Judit Mészáros, Jenna H. Eysteinsdóttir, Ragna H. Thorleifsdóttir, Sigrídur K. Hrafnkelsdóttir, Heida B. Bragadóttir, Saemundur Oddsson, and Jonathan I. Silverberg

Link

Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study, Sigrídur Lára Gudmundsdóttir, Tommaso Ballarini, María L. Ámundadóttir, Judit Mészáros, Jenna H. Eysteinsdóttir, Ragna H. Thorleifsdóttir, Sigrídur K. Hrafnkelsdóttir, Heida B. Bragadóttir, Saemundur Oddsson, and Jonathan I. Silverberg

Link

Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies, Emma Guttman-Yassky, Jacob P. Thyssen, Jonathan I. Silverberg, Kim A. Papp, Amy S. Paller, Stephan Weidinger, H Chih-Ho Hong, Barbara Hendrickson, Deanne Dilley, Allan R. Tenorio, Barry Ladizinski, Alvina D. Chu, John Liu, and Alan D. Irvine

Link

Psychological Interventions Are More Effective Than Educational Interventions at Improving Atopic Dermatitis Severity: A Systematic Review, Tammy Hua, Lori S. Kim, Muhammad Yousaf, Eran C. Gwillim, Yik W. Yew, Brad Lee, Kevin Hua, Taylor Erickson, Brian Cheng, Kevin Patel, and Jonathan Ian Silverberg

Link

Assessment of the validity of international classification of disease tenth revision codes for atopic dermatitis, Sneha Iyer, Nisha Patel, Eric Sanfilippo, Robert P. Dellavalle, and Jonathan I. Silverberg

Link

Tropical parasitic itch in returned travellers and immigrants from endemic areas, T Ju, A Vander Does, G Ingrasci, S A. Norton, and G Yosipovitch

Link

Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review, Trisha Kaundinya, Uros Rakita, Armaan Guraya, Donna Maria Abboud, Emily Croce, Jacob P. Thyssen, Andrew Alexis, and Jonathan I. Silverberg

Link

Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patients, Jonette Keri, Fran E. Cook-Bolden, Lawrence Green, Leon H. Kircik, Hilary Baldwin, William Philip Werschler, Eric Guenin, Radhakrishnan Pillai, and Varsha Bhatt

Link

Feeling the burn: Sunburn recall in staphylococcal scalded skin syndrome, Rayva Khanna, Emily L. Guo, and Anna Yasmine Kirkorian

Link

Dermal sensitization, safety, tolerability, and patient preference of tazarotene 0.045% lotion from five clinical trials, Leon H. Kircik, Lawrence Green, Eric Guenin, Waleed Khalid, and Binu Alexander

Link

Combination 1550 nm non-ablative fractional resurfacing and laser hair removal for treatment of Becker's nevi in skin types III-VI, Shelby L. Kubicki, Emily L. Guo, Pooja Sodha, Heather Richmond, and Paul M. Friedman

Link

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials, Mark G. Lebwohl, Leon H. Kircik, Angela Y. Moore, Linda Stein Gold, Zoe D. Draelos, Melinda J. Gooderham, Kim A. Papp, Jerry Bagel, Neal Bhatia, James Q. Del Rosso, Laura K. Ferris, Lawrence J. Green, Adelaide A. Hebert, Terry Jones, Steven E. Kempers, David M. Pariser, Paul S. Yamauchi, Matthew Zirwas, Lorne Albrecht, Alim R. Devani, Mark Lomaga, Amy Feng, Scott Snyder, Patrick Burnett, Robert C. Higham, and David R. Berk

Link

Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis, Mark G. Lebwohl, Linda Stein Gold, James Q. Del Rosso, Lawrence Green, and Abby Jacobson

Link

Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years, Thomas A. Luger, Adelaide A. Hebert, Andrea L. Zaenglein, Jonathan I. Silverberg, Huaming Tan, William C. Ports, and Michael A. Zielinski

Link

Longitudinal Course of Sleep Disturbance and Relationship With Itch in Adult Atopic Dermatitis in Clinical Practice, Jaya Manjunath, Donald Lei, Adnan Ahmed, Marissa Ayasse, Rajeev Chavda, Sylvie Gabriel, and Jonathan Ian Silverberg

Link

Association of obesity in early childhood with atopic dermatitis in late childhood and adolescence, Jaya Manjunath and Jonathan I. Silverberg

Link

A dialysis patient with subungual hyperkeratosis and ulceration of the fingertips, Sarah H. Millan, Karl M. Saardi, Ardeshir Edward Nadimi, and Scott A. Norton

Link

Racial disparities in dermatology, Shanthi Narla, Candrice R. Heath, Andrew Alexis, and Jonathan I. Silverberg

Link

The suitability of treating atopic dermatitis with Janus kinase inhibitors, Shanthi Narla and Jonathan I. Silverberg

Link

Practices and perspectives on medical cannabis and cannabinoids: A survey of the National Psoriasis Foundation Medical Advisory Board, Dillon Nussbaum, Sapana Desai, Adrianna Gonzalez-Lopez, Jason E. Hawkes, George Gondo, and Adam Friedman

Link

Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology, Dillon Nussbaum, Chapman Wei, Haig Pakhchanian, Rahul Raiker, Ivan Z. Liu, and Adam Friedman

Link

Reply to "Pityriasis rosea during COVID-19 and its pathogenesis", Dillon Nussbaum, Chapman Wei, Haig Pakhchanian, Rahul Raiker, Ivan Z. Liu, and Adam Friedman

Link

Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis, Paul Oykhman, Jared Dookie, Husam Al-Rammahy, Anna de Benedetto, Rachel N. Asiniwasis, Jennifer LeBovidge, Julie Wang, Peck Y. Ong, Peter Lio, Alvin Gutierrez, Korey Capozza, Stephen A. Martin, Winfred Frazier, Kathryn Wheeler, Mark Boguniewicz, Jonathan M. Spergel, Matthew Greenhawt, Jonathan I. Silverberg, Lynda Schneider, and Derek K. Chu

Link

The utility of laboratory testing for pediatric patients undergoing isotretinoin treatment, Varsha Parthasarathy, Nidhi Shah, and Anna Yasmine Kirkorian

PDF

Cutaneous squamous cell carcinoma staging may influence management in users: A survey study., Vishal A. Patel, Catherine McCullum, Andrew D. Sparks, Chrysalyne D Schmults, Sarah T Arron, and Anokhi Jambusaria-Pahlajani

Link

A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis, A Pinter, L J. Green, J Selmer, M Praestegaard, L S. Gold, and M Augustin

Link

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitis, J Puelles, F Fofana, D Rodriguez, J I. Silverberg, A Wollenberg, C Dias Barbosa, M Vernon, R Chavda, S Gabriel, and C Piketty

Link

Association of atopic dermatitis severity with menstrual worsening of disease in women: a cross-sectional study., U Rakita, T Kaundinya, and J I. Silverberg

Link

Associations between onychomycosis and COVID-19 clinical outcomes: a retrospective cohort study from a US metropolitan center, Uros Rakita, Trisha Kaundinya, Armaan Guraya, Kamaria Nelson, Brittany Maner, Jaya Manjunath, Gabrielle Schwartzman, Brittany Lane, and Jonathan I. Silverberg

Link

Differences between pediatric and adult atopic dermatitis, Hassiel A. Ramírez-Marín and Jonathan I. Silverberg

Link

Food allergy testing in atopic dermatitis, Hassiel A. Ramírez-Marín, Anne Marie Singh, Peck Y. Ong, and Jonathan I. Silverberg

Link

Prevalence and associations of fatigue in childhood atopic dermatitis: a cross-sectional study, Stephanie M. Rangel, Theodore Kim, Anjani Sheth, Alli Blumstein, Jin-Shei Lai, David Cella, Amy S. Paller, and Jonathan I. Silverberg

Link

Numerous Angiomatous Lesions in an Infant, Catherine Reilly, Nidhi Shah, and Kaiane Habeshian

Link

Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis, Alex M. Rokni, Marissa Ayasse, Adnan Ahmed, Lauren Guggina, Robert W. Kantor, and Jonathan I. Silverberg

Link

Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study, Maria C. Schneeweiss, Julien Kirchgesner, Richard Wyss, Yinzhu Jin, Cassandra York, Joseph F. Merola, Arash Mostaghimi, Jonathan I. Silverberg, Sebastian Schneeweiss, and Robert J. Glynn